HER2 STANDS WITH YOU

Sign up for support tailored to people with HER2+ mBC and their loved ones

HER2 stands with you

About HER2 Stands With You

HER2 Stands With You is a support program specifically designed for people diagnosed with HER2-expressing (IHC 1+ through IHC 3+) metastatic breast cancer (mBC) who are taking, or considering, ENHERTU and the people who are close to them.

This program shares information and resources on HER2+ mBC and ENHERTU, helping you feel more comfortable with what to expect on the road ahead. This includes:

  • Financial support programs to help you afford treatment
  • Information about what to expect when starting ENHERTU

What is ENHERTU?

ENHERTU is a prescription medicine used to treat adults who have:

  • Human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment:
    • for metastatic disease, or
    • have breast cancer that has come back during or within 6 months of completing treatment for their early-stage breast cancer.

It is not known if ENHERTU is safe and effective in children.

HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry.

Photo of woman in confident pose: With ENHERTU® (fam-trastuzumab deruxtecan-nxki), I stand determined. Photo of woman in confident pose: With ENHERTU® (fam-trastuzumab deruxtecan-nxki), I stand determined. Photo of woman in confident pose: With ENHERTU® (fam-trastuzumab deruxtecan-nxki), I stand determined.
Not an actual patient.